Antiviral vaccines license t cell responses by suppressing granzyme b levels in human plasmacytoid dendritic cells

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1144-1153

  Fabricius, Dorit ^a   Nubaum, Benedikt ^a   Busch, Daniel ^a   Panitz, Verena ^a   Mandel, Birgit ^a   Vollmer, Angelika ^a   Westhoff, Mike Andrew ^a   Kaltenmeier, Christof ^b   Lunov, Oleg ^b   Tron, Kyrylo ^b   Nienhaus, G Ulrich ^c   Jahrsdorfer, Bernd ^b   Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; IPV; MASERN; MEASLES VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; RUBELLA VACCINE; T LYMPHOCYTE RECEPTOR; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE; VIRUS VACCINE; YELLOW FEVER VACCINE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME REPRESSION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TICK BORNE ENCEPHALITIS; ZETA CHAIN;

CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; GRANZYMES; HUMANS; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; VIRAL VACCINES;

EID: 84880658077     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203479     Document Type: Article

References (54)

1. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594-606.
2. Schettini, J., and P. Mukherjee. 2008. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin. Dev. Immunol. 2008: 106321.
3. Swiecki, M., and M. Colonna. 2010. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234: 142-162.
4. Waldner, H. 2009. The role of innate immune responses in autoimmune disease development. Autoimmun. Rev. 8: 400-404.
5. Di Pucchio, T., B. Chatterjee, A. Smed-Sörensen, S. Clayton, A. Palazzo, M. Montes, Y. Xue, I. Mellman, J. Banchereau, and J. E. Connolly. 2008. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9: 551-557.
6. Jahrsdörfer, B., A. Vollmer, S. E. Blackwell, J. Maier, K. Sontheimer, T. Beyer, B. Mandel, O. Lunov, K. Tron, G. U. Nienhaus, et al. 2010. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 115: 1156-1165.
7. Chowdhury, D., and J. Lieberman. 2008. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26: 389-420.
8. Lord, S. J., R. V. Rajotte, G. S. Korbutt, and R. C. Bleackley. 2003. Granzyme B: a natural born killer. Immunol. Rev. 193: 31-38.
9. Buzza, M. S., and P. I. Bird. 2006. Extracellular granzymes: current perspectives. Biol. Chem. 387: 827-837.
10. Hagn, M., E. Schwesinger, V. Ebel, K. Sontheimer, J. Maier, T. Beyer, T. Syrovets, Y. Laumonnier, D. Fabricius, T. Simmet, and B. Jahrsdörfer. 2009. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J. Immunol. 183: 1838-1845.
11. Jahrsdörfer, B., S. E. Blackwell, J. E. Wooldridge, J. Huang, M. W. Andreski, L. S. Jacobus, C. M. Taylor, and G. J. Weiner. 2006. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood 108: 2712-2719.
12. Berthou, C., J. P. Marolleau, C. Lafaurie, A. Soulié, L. Dal Cortivo, J. F. Bourge, M. Benbunan, and M. Sasportes. 1995. Granzyme B and perforin lytic proteins are expressed in CD34+ peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood 86: 3500-3506.
13. Tschopp, C. M., N. Spiegl, S. Didichenko, W. Lutmann, P. Julius, J. C. Virchow, C. E. Hack, and C. A. Dahinden. 2006. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood 108: 2290-2299.
14. Strik, M. C., P. J. de Koning, M. J. Kleijmeer, B. A. Bladergroen, A. M.Wolbink, J. M. Griffith, D. Wouters, Y. Fukuoka, L. B. Schwartz, C. E. Hack, et al. 2007. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol. Immunol. 44: 3462-3472.
15. Korthals, M., N. Safaian, R. Kronenwett, D. Maihöfer, M. Schott, C. Papewalis, E. Diaz Blanco, M. Winter, A. Czibere, R. Haas, et al. 2007. Monocyte derived dendritic cells generated by IFN-A acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J. Transl. Med. 5: 46.
16. Rissoan, M. C., T. Duhen, J. M. Bridon, N. Bendriss-Vermare, C. Péronne, B. de Saint Vis, F. Briére, and E. E. Bates. 2002. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 100: 3295-3303.
17. Romero, V., E. Fellows, D. E. Jenne, and F. Andrade. 2009. Cleavage of La protein by granzyme H induces cytoplasmic translocation and interferes with Lamediated HCV-IRES translational activity. Cell Death Differ. 16: 340-348.
18. Afonina, I. S., G. A. Tynan, S. E. Logue, S. P. Cullen, M. Bots, A. U. Lüthi, E. P. Reeves, N. G. McElvaney, J. P. Medema, E. C. Lavelle, and S. J. Martin. 2011. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1a. Mol. Cell 44: 265-278.
19. Wieckowski, E., G. Q. Wang, B. R. Gastman, L. A. Goldstein, and H. Rabinowich. 2002. Granzyme B-mediated degradation of T-cell receptor z chain. Cancer Res. 62: 4884-4889.
20. Froelich, C. J., J. Pardo, and M. M. Simon. 2009. Granule-Associated serine proteases: granzymes might not just be killer proteases. Trends Immunol. 30: 117-123.
21. Devadas, S., J. Das, C. Liu, L. Zhang, A. I. Roberts, Z. Pan, P. A. Moore, G. Das, and Y. Shi. 2006. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 25: 237-247.
22. Gondek, D. C., L. F. Lu, S. A. Quezada, S. Sakaguchi, and R. J. Noelle. 2005. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174: 1783-1786.
23. Amanna, I. J., and M. K. Slifka. 2011. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 411: 206-215.
24. Plotkin, S. A. 2010. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17: 1055-1065.
25. Co, M. D., M. Terajima, J. Cruz, F. A. Ennis, and A. L. Rothman. 2002. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293: 151-163.
26. Arvin, A. M. 1992. Cell-mediated immunity to varicella-zoster virus. J. Infect. Dis. 166(Suppl. 1): S35-S41.
27. Querec, T., S. Bennouna, S. Alkan, Y. Laouar, K. Gorden, R. Flavell, S. Akira, R. Ahmed, and B. Pulendran. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203: 413-424.
28. Barrat, F. J., T. Meeker, J. Gregorio, J. H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, and R. L. Coffman. 2005. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202: 1131-1139.
29. Fabricius, D., M. S. O'Dorisio, S. Blackwell, and B. Jahrsdörfer. 2006. Human plasmacytoid dendritic cell function: inhibition of IFN-A secretion and modulation of immune phenotype by vasoactive intestinal peptide. J. Immunol. 177: 5920-5927.
30. de Vries, I. J., J. Tel, D. Benitez-Ribas, R. Torensma, and C. G. Figdor. 2011. Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses. Mol. Immunol. 48: 810-817.
31. Tel, J., E. L. Smits, S. Anguille, R. N. Joshi, C. G. Figdor, and I. J. de Vries. 2012. Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities. Blood 120: 3936-3944.
32. Matta, B. M., A. Castellaneta, and A. W. Thomson. 2010. Tolerogenic plasmacytoid DC. Eur. J. Immunol. 40: 2667-2676.
33. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
34. Hoeffel, G., A. C. Ripoche, D. Matheoud, M. Nascimbeni, N. Escriou, P. Lebon, F. Heshmati, J. G. Guillet, M. Gannagé, S. Caillat-Zucman, et al. 2007. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27: 481-492.
35. Swiecki, M., and M. Colonna. 2010. Accumulation of plasmacytoid DC: roles in disease pathogenesis and targets for immunotherapy. Eur. J. Immunol. 40: 2094-2098.
36. Boasso, A., J. P. Herbeuval, A.W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer. 2007. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109: 3351-3359.
37. Ito, T., M. Yang, Y. H. Wang, R. Lande, J. Gregorio, O. A. Perng, X. F. Qin, Y. J. Liu, and M. Gilliet. 2007. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204: 105-115.
38. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
39. Lindner, S., K. Dahlke, K. Sontheimer, M. Hagn, C. Kaltenmeier, T. F. Barth, T. Beyer, F. Reister, D. Fabricius, R. Lotfi, et al. 2013. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 73: 2468-2479.
40. Schreibelt, G., D. Benitez-Ribas, D. Schuurhuis, A. J. Lambeck, M. van Hout-Kuijer, N. Schaft, C. J. Punt, C. G. Figdor, G. J. Adema, and I. J. de Vries. 2010. Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells. Blood 116: 564-574.
41. Hoves, S., V. R. Sutton, N. M. Haynes, E. D. Hawkins, D. Fernández Ruiz, N. Baschuk, K. A. Sedelies, M. Schnurr, J. Stagg, D. M. Andrews, et al. 2011. A critical role for granzymes in antigen cross-presentation through regulating phagocytosis of killed tumor cells. J. Immunol. 187: 1166-1175.
42. Hoves, S., V. R. Sutton, and J. A. Trapani. 2012. A novel role for granzymes in anti-tumor immunity. OncoImmunology 1: 219-221.
43. Casciola-Rosen, L., F. Andrade, D. Ulanet, W. B. Wong, and A. Rosen. 1999. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190: 815-826.
44. Casciola-Rosen, L., A. Miagkov, K. Nagaraju, F. Askin, L. Jacobson, A. Rosen, and D. B. Drachman. 2008. Granzyme B: evidence for a role in the origin of myasthenia gravis. J. Neuroimmunol. 201-202: 33-40.
45. Stefanova, I., J. R. Dorfman, M. Tsukamoto, and R. N. Germain. 2003. On the role of self-recognition in T cell responses to foreign antigen. Immunol. Rev. 191: 97-106.
46. Drobits, B., M. Holcmann, N. Amberg, M. Swiecki, R. Grundtner, M. Hammer, M. Colonna, and M. Sibilia. 2012. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J. Clin. Invest. 122: 575-585.
47. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, et al. 2006. Interferonproducing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12: 207-213.
48. Guimont-Desrochers, F., G. Boucher, Z. Dong, M. Dupuis, A. Veillette, and S. Lesage. 2012. Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation. Blood 119: 4349-4357.
49. Stary, G., C. Bangert, M. Tauber, R. Strohal, T. Kopp, and G. Stingl. 2007. Tumoricidal activity of TLR7/8-Activated inflammatory dendritic cells. J. Exp. Med. 204: 1441-1451.
50. Cavaleiro, R., A. P. Baptista, R. S. Soares, R. Tendeiro, R. B. Foxall, P. Gomes, R. M. Victorino, and A. E. Sousa. 2009. Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease. PLoS Pathog. 5: e1000667.
51. Koyama, S., T. Aoshi, T. Tanimoto, Y. Kumagai, K. Kobiyama, T. Tougan, K. Sakurai, C. Coban, T. Horii, S. Akira, and K. J. Ishii. 2010. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci. Transl. Med. 2: 25ra24.
52. Grouard, G., M. C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y. J. Liu. 1997. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185: 1101-1111.
53. Beckebaum, S., X. Zhang, X. Chen, Z. Yu, A. Frilling, G. Dworacki, H. Grosse-Wilde, C. E. Broelsch, G. Gerken, and V. R. Cicinnati. 2004. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin. Cancer Res. 10: 7260-7269.
54. Aldinucci, D., K. Olivo, D. Lorenzon, D. Poletto, A. Gloghini, A. Carbone, and A. Pinto. 2005. The role of interleukin-3 in classical Hodgkin's disease. Leuk. Lymphoma 46: 303-311.